MIANSERIN: 2,554 Adverse Event Reports & Safety Profile
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
2,554
Total FAERS Reports
488 (19.1%)
Deaths Reported
1,473
Hospitalizations
2,554
As Primary/Secondary Suspect
290
Life-Threatening
74
Disabilities
Active Ingredient: MIANSERIN HYDROCHLORIDE ·
First Report: 199108 · Latest Report: 20250806
What Are the Most Common MIANSERIN Side Effects?
#1 Most Reported
Toxicity to various agents
246 reports (9.6%)
#2 Most Reported
Fall
201 reports (7.9%)
#3 Most Reported
Coma
177 reports (6.9%)
All MIANSERIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Toxicity to various agents | 246 | 9.6% | 126 | 82 |
| Fall | 201 | 7.9% | 34 | 163 |
| Coma | 177 | 6.9% | 41 | 99 |
| Somnolence | 163 | 6.4% | 27 | 98 |
| Off label use | 141 | 5.5% | 42 | 79 |
| Drug abuse | 132 | 5.2% | 60 | 40 |
| Confusional state | 126 | 4.9% | 19 | 89 |
| Hyponatraemia | 122 | 4.8% | 11 | 112 |
| Hypotension | 113 | 4.4% | 10 | 82 |
| Poisoning deliberate | 107 | 4.2% | 11 | 68 |
| Agranulocytosis | 102 | 4.0% | 18 | 66 |
| Nausea | 102 | 4.0% | 54 | 79 |
| Overdose | 88 | 3.5% | 44 | 45 |
| Hepatocellular injury | 85 | 3.3% | 6 | 70 |
| Drug ineffective | 81 | 3.2% | 2 | 49 |
| Hepatic cytolysis | 74 | 2.9% | 36 | 33 |
| Acute kidney injury | 73 | 2.9% | 27 | 45 |
| Cholestasis | 72 | 2.8% | 7 | 48 |
| Ischaemic stroke | 69 | 2.7% | 45 | 57 |
| Drug reaction with eosinophilia and systemic symptoms | 68 | 2.7% | 23 | 41 |
Who Reports MIANSERIN Side Effects? Age & Gender Data
Gender: 60.6% female, 39.4% male. Average age: 63.9 years. Most reports from: FR. View detailed demographics →
Is MIANSERIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2001 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 2 | 0 | 1 |
| 2009 | 4 | 1 | 4 |
| 2010 | 3 | 0 | 1 |
| 2011 | 15 | 1 | 11 |
| 2012 | 12 | 0 | 7 |
| 2013 | 19 | 4 | 10 |
| 2014 | 95 | 3 | 58 |
| 2015 | 82 | 4 | 73 |
| 2016 | 121 | 34 | 99 |
| 2017 | 178 | 31 | 134 |
| 2018 | 263 | 53 | 181 |
| 2019 | 236 | 40 | 131 |
| 2020 | 272 | 12 | 188 |
| 2021 | 190 | 12 | 116 |
| 2022 | 180 | 32 | 79 |
| 2023 | 159 | 34 | 79 |
| 2024 | 122 | 21 | 73 |
| 2025 | 74 | 13 | 41 |
What Is MIANSERIN Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 921 |
| Depression | 744 |
| Bipolar disorder | 79 |
| Anxiety | 59 |
| Mixed anxiety and depressive disorder | 59 |
| Major depression | 49 |
| Insomnia | 43 |
| Sleep disorder | 36 |
| Intentional overdose | 35 |
| Poisoning deliberate | 35 |
MIANSERIN vs Alternatives: Which Is Safer?
MIANSERIN vs MICAFUNGIN
MIANSERIN vs MICARDIS
MIANSERIN vs MICONAZOLE
MIANSERIN vs MIDAZOLAM
MIANSERIN vs MIDAZOLAM\MIDAZOLAM
MIANSERIN vs MIDODRINE
MIANSERIN vs MIDOMAFETAMINE
MIANSERIN vs MIDOSTAURIN
MIANSERIN vs MIFEPRISTONE
MIANSERIN vs MIGALASTAT
Official FDA Label for MIANSERIN
Official prescribing information from the FDA-approved drug label.